NielsenIQ Mid-Year Consumer Outlook: Guide to 2025 RevealsCatalysts to Change in Key Verticals Across Industries
23.9.2024 16:00:00 CEST | Business Wire | Press release
Increased entrepreneurship, with 64% of respondents actively seeking additional income streamsBuying decisions increasingly influenced by AI, with 40% of consumers willing to use AI to enhance daily shopping decisionsMacro 2025 catalysts: AI readiness, GLP-1 ripple effect, omnichannel evolution, and commodity costs
NielsenIQ (NIQ), the world’s leading global consumer intelligence company, has released its much-anticipated Mid-Year Consumer Outlook: Guide to 2025 report, identifying macro catalysts across industries. The forward-looking study found consumers remain determined and resilient despite the uncertainty, providing a strategic roadmap for retailers looking to win over consumers over the next 12–18 months and beyond.
The report anticipates that global consumers will spend $3.2 trillion more in 2025, representing nearly 6% growth compared with 2024, according to World Data Lab.
With the global economy facing ongoing and unprecedented challenges, understanding consumer behavior has become mission-critical for businesses seeking to thrive in an ever-evolving landscape. NIQ’s semi-annual study offers a comprehensive analysis of the impact of economic events and trends on consumer confidence, changes in consumer attitudes, and important insights into the factors influencing purchasing decisions. The report also explores regional variances, providing in-depth analysis of the unique dynamics of Asia Pacific, Europe, North America, the Middle East, and Latin America.
With looming uncertainty around geopolitical crises, economic stability, and environmental health, consumers are becoming resilient and are spending where it matters most. This shows a determinedshift from cautious to intentional consumption, with a focus on a sense of prosperity and well-being.
“There is increasing demand for AI-driven insights based on large quantities of granular data that only NIQ can deliver,” said Tracey Massey, COO of NIQ. “Having your finger on the pulse of current and expected consumer behavior that is benchmarked globally is now table stakes to establish and maintain any competitive advantage.”
Global catalysts to change in 2025:
- Readiness for AI: 40% of consumers would accept a product recommendation from their AI assistant, and 40% would leverage AI to automate and speed up their everyday shopping decisions, making it essential for companies to assess which AI advancements are going to appeal to consumers and provide options to support older consumers.
- The rise and impact of GLP-1 drugs: 31% of global consumers are likely to use a medication or drug to support weight loss, but GLP-1 medications will drive a wide scope of impact by inspiring new spending sources, influencing consumer lifestyles, and shaping norms of interpersonal behavior.
- Omnichannel evolution: The social commerce revolution has led to the evolution of omni, with an 11.6% increase in global online sales performance and the rise of gamification, with 36% of consumers saying they would spend more on a purchase because of an in-app experience.
- Hot commodity costs: 60% of respondents said they will buy fewer snacks and confectionery products if prices continue to increase or remain high for the next three months—the highest ‘dropout' response across all surveyed categories. Cocoa (+128%), Coffee (+43%), and Milk (+44%) are "hot commodities," according to measures by Trading Economics, with rising prices impacting volume sales of related categories/products.
Top trends framing expected 2025 spending:
-
Consumers’ top concern remains rising food prices (33%), followed by increasing utilities costs (20%) and the threat of an economic downturn (19%). Climate change is fourth (14%), owing to the numerous extreme weather events around the world.
- A majority (67%) of surveyed consumers around the globe say they are likely to change or try a new brand because of lower pricing.
-
They intend to continue cutting back on non-essentials like Out-of-Home (OOH) Dining (38%), Out-of-Home Entertainment (37%), and Food Delivery/Takeaways (36%). Expect to see decreased spend on OOH activities, while intentional choices around In-Home Entertainment (48%) and spending on Socializing/Gatherings (46%) are likely to be maintained in 2025.
- Meanwhile, private label product interest continues to rise, with 50% of consumers buying more private label products than ever. What’s more, 40% of global consumers say they would switch to a private label product they enjoy, even if it costs more.
-
North American consumers worry most about rising housing costs, while global conflict is a top concern for Africa, Middle East, and Europe.
- The pace of monthly consumer packaged goods (CPG) inflation continues to slow across countries, down to less than 2% growth YoY. Regionally, CPG inflation is also trending down, but it remains higher than average in Latin America and Africa. Monthly global prices have risen fastest in Latin America, which has seen as much as 9% YoY growth.
- Upselling opportunities: Intentional consumers are willing to pay a premium for worthwhile attributes. In Tech & Durables, unit sales of premium priced smart / mobile phones are up 17% in 2023 vs. 2019, compared with economy options, which are down 32% in the same period.
“Over the past six months, there has been a determined shift from cautious to intentional consumption habits. Consumers are willing to spend more but remain conscious of potential changes,” said Lauren Fernandes, Vice President, Global Thought Leadership, NIQ. “Consumers are seeking value with every purchase in multiple ways. They are spreading their spending very purposefully—and expect to leverage any excess in strategic ways in 2025 and beyond.”
NIQ’s Mid-Year Consumer Outlook: Guide to 2025 provides key insights for businesses to navigate trends and strategically plan for sustainable growth. The report highlights a significant shift in consumer behavior—from cautious to intentional consumption.
To learn more, download the report today and sign up for our global webinar, being held Sept. 24, 2024, at 10 a.m. EST. Click on the link to register for the event.
About NIQ:
NIQ is the world’s leading global consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together the two industry leaders with unparalleled global reach. Today, NIQ has operations in 95+ countries representing 97% of the world’s GDP. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™. For more information, please visit www.niq.com
About Mid-Year Consumer Outlook: Guide to 2025:
NIQ’s Mid-Year Consumer Outlook 2024 provides an analytic assessment of the state of consumers, based on a global footprint of consumer intelligence solutions and the feedback of over 17,000 online consumers in 23 countries. The goal: to better understand their current thinking about the economic environment, as well as what they're buying—and why. The survey was conducted between June and July 2024.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240923781286/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom